# Haemocomplettan® P During Elective Complex Cardiac Surgery

> **NCT01124981** · PHASE2,PHASE3 · COMPLETED · sponsor: **Isala** · enrollment: 120 (estimated)

## Conditions studied

- Fibrinogen Deficiency in Complex Cardiac Surgery

## Interventions

- **DRUG:** Haemocomplettan® P
- **DRUG:** Human albumin (Placebo)

## Key facts

- **NCT ID:** NCT01124981
- **Lead sponsor:** Isala
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2014-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01124981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01124981, "Haemocomplettan® P During Elective Complex Cardiac Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01124981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*